MSF calls on Japan and South Korea to drop the harmful RCEP measures
Japan and South Korea are aggressively pushing for measures in the RCEP agreement that would emphasise stronger pharma corporation…
Author
BIOLABEX opens R&D laboratory in BioPark Mauritius
The company aims to develop the best solutions to suit the business needs of clients, in compliance with international standards
Market trends driving new advanced drug delivery devices in injectable space
Kirat Majumdar, Business Director, BD Medical - Pharmaceutical Systems elaborates on how companies like BD are catering to varied…
Thermo Fischer & TUM announce milestone on human proteomes
Report on synthesis of a library of over 330,000 reference peptides to analyse human proteomes
MoH&FW undertakes drug survey for determining quality of drugs
The statistical design of the drug survey included as many as 224 drug molecules belonging to 15 different therapeutic categories…
Oncology companion diagnostics market will approach $414 million by 2023: GlobalData
APAC region to see highest growth rate driven by increased evidence and increasing uptake of low-cost molecular tests
Asia-Pacific seasonal influenza vaccines market to surpass $1.7 billion by 2022: GBI Research
Growth will primarily be driven by increasing affordability, rising healthcare access in India and China, and subsidised…
Antibacterial drugs market will hit $35.6 billion by 2022, as efforts increase to tackle…
Use of protein synthesis inhibitors to grow but vaccines will be leading revenue generating drugs
All bluster and no lustre?
With little or no financial incentives in Union Budget 2017, the pharmaceutical industry remains deprived of a cure for its…
AYUSH Minister to inaugurate World Integrated Medicine Forum on Regulation of Homeopathic Medicine
MoU to be signed between Homoeopathic Pharmacopoeia Convention of the US and CCRH in the field of Homoeopathic Medicine